ARTHRO SYSTEM - (Page 8)

Riferimenti bibliografici 1. D’Amico LL et al. Relationships of hip joint volume ratios with degrees of joint laxity and degenerative disease from youth to maturity in a canine population predisposed to hip joint osteoarthritis. Am J Vet Res. 2011; 72(3):376-83 [Cod. 16307] 2. Paster ER et al. Ununited medial epicondyle of the humerus: radiographic prevalence and association with elbow osteoarthritis in a cohort of Labrador Retrievers. Vet Surg. 2009; 38: 169-72 [Cod. 14611] 3. Comerford EJ et al. Update on the aetiopathogenesis of canine cranial cruciate ligament disease. Vet Comp Orthop Traumatol 2011; 24(2): 9198 [Cod. 16278] 4. Hardie E et al. Radiographic evidence of degenerative joint disease in geriatric cats: 100 cases (1994-1997). J Am Vet Med Assoc. 2002; 220(5):628-32 [Cod. 392] 5. Clarke SP, Bennett D. Feline osteoarthritis: a prospective study of 28 cases. J Small Anim Pract. 2006; 47(8):439-45 [Cod. 12525] 6. Lascelles BD. Feline degenerative joint disease. Vet Surg 2010, 39: 2-13 [Cod. 15365] 7. Lascelles BD. DJD-associated pain in cats. What can we do to promote patient comfort? J Feline Med Surg 2010; 12: 200-212 [Cod. 15592] 8. Bennett D, Morton A. A study of owner observed behavioural and lifestyle changes in cats with musculoskeletal disease before and after analgesic therapy. J Feline Med Surg. 2009; 11(12):997-1004 [Cod. 15959] 9. Clements DN et al. A candidate gene study of canine joint diseases. J Hered. 2010; 101(1):54-6 [Cod. 15473] 10. Ginja MM et al. Diagnosis, genetic control and preventive management of canine hip dysplasia: a review. Vet J. 2010;184(3):269-76 [Cod. 14887] 11. Rychel JK. Diagnosis and treatment of osteoarthritis. Top Companion Anim Med. 2010; 25(1):20-5 [Cod. 15624] 12. Johnston SA et al. Canine osteoarthritis. Overview, therapies & nutrition. Clinician’s update. Supplement to NAVC Clinician’s Brief, April 2009 [Cod. 15114] 13. Verbruggen G. Chondroprotective drugs in degenerative joint diseases. Rheumatology. 2006 45(2):129-38 [Cod. 12031] 14. Fox SM, Millis D. Gestione multimodale dell’artrosi del cane. Manson Publishing ed. Prima edizione Italiana a cura di Innovet e EV (Edizioni Veterinarie), 2011 15. Mortellaro CM, Miolo A. Approccio medico combinato all’artrosi del cane. Veterinaria, 2004, 18(3): 9-19 [Cod. 8137] 16. Sanderson RO et al. Systematic review of the management of canine osteoarthritis. Vet Rec. 2009; 164(14):418-24 [Cod. 14798] 17. Johnston SA et al. Nonsurgical management of osteoarthritis in dogs. Vet Clin North Am Small Anim Pract. 2008; 38(6):1449-70 [Cod. 14505] 18. Aragon CL et al. Systematic review of clinical trials of treatments for osteoarthritis in dogs. J Am Vet Med Assoc. 2007; 230(4):514-21 [Cod. 12920] 19. Renberg WC. Pathophysiology and management of arthritis. Vet Clin North Am Small Anim Pract. 2005; 35(5):1073-91 [Cod. 11930] 20. Miolo A. Glupamid®: effetti anti-artrosici di una nuova forma di glucosamina. Comunicazione libera “Orthofun 2011”, Palermo, maggio 2011 21. della Valle MF. Effects of Glupamid (N-palmitoyl-D-glucosamine) on osteoarthritis pain and inflammation. 2nd VEPRA Conference “Spinal cord trauma: physical therapy and rehabilitation”, Warsaw (Poland), 17th-18th September 2011 22. Vangness CT et al. A review of evidence-based medicine for glucosamine and chondroitin sulfate use in knee osteoarthritis. Arthroscopy. 2009; 25(1):86-94 [Cod. 14526] 23. Neil KM et al. The role of glucosamine and chondroitin sulfate in treatment for and prevention of osteoarthritis in animals. J Am Vet Med Assoc. 2005; 226(7): 1079-88 [Cod. 11587] 24. Lippiello L. Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under simulated conditions of joint stress. Osteoarthritis Cartilage. 2003; 11(5):335-42 [Cod. 2423] 25. Re G et al. Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and 26. 27. pain: Potential use in companion animals. Vet J. 2007; 173(1):23-32 [Cod. 11977] Petrosino S et al. N-palmitoylethanolamine: Biochemistry and new therapeutic opportunities. Biochimie. 2010;92(6):724-7 [Cod. 15443] Costa B et al. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB1, TRPV1 and PPARgamma receptors and neurotrophic factors. Pain 2008; 139(3): 541-50 [Cod. 1872] Miolo A et al. Effetti di una nuova forma di glucosamina sulla degranulazione dei mastociti. Studio in vitro. Veterinaria, 2007, 21(6): 23-28 [Cod. 1916] Miolo A et al. Glupamid®: a novel nutraceutical approach to canine and feline osteoarthritis. J Vet Pharmacol Ther. 2006; 29 Suppl 1:202-3 [Cod. 12510] Costa B et al. Effect of Glupamid (N-palmitoyl-D-glucosamine) on knee osteoarthritis pain. Proceedings WVOC (World Veterinary Orthopedic) Congress 2010, September 15-18, Bologna, Italy, pp. 553-4.[Cod. 15611] Costa B et al. Glupamid® vs glucosamina nell’artrosi del ginocchio. Atti 71° congresso nazionale SCIVAC, Arezzo, 21-23 ottobre 2011 [Cod. 16259] Adebowale A et al. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharm Drug Dispos. 2002; 23(6):217-25.[Cod. 2647] Volpi N. Quality of different chondroitin sulfate preparations in relation to their therapeutic activity. J Pharm Pharmacol. 2009; 61(10):1271-80 [Cod. 15245] Volpi N. Influence of charge density, sulfate group position and molecular mass on adsorption of chondroitin sulfate onto coral. Biomaterials. 2002; 23(14):3015-22.[Cod. 10626] Handley CJ et al. Extracellular matrix metabolism by chondrocytes. 7. Evidence that L-glutamine is an essential amino acid for chondrocytes and other connective tissue cells. Biochim Biophys Acta. 1980; 627(3):324-31 [Cod. 14461] Tonomura H et al. Glutamine protects articular chondrocytes from heat stress and NO-induced apoptosis with HSP70 expression. Osteoarthritis Cartilage. 2006; 14(6):545-53 [Cod. 14404] Jerosch J. Effects of glucosamine and chondroitin sulfate on cartilage metabolism in OA: outlook on other nutrient partners especially omega-3 fatty acids. Int J Rheumatol. 2011; 969012, Epub 2011 Aug 2. [Cod. 16689] Ferro E, Miolo A. Nuove prospettive nella prevenzione e nel trattamento dell’artrosi del cane in crescita: acido DL-alfa-lipoico. Veterinaria 2002; 16(1): 9-17 [Cod. 4273] Kinnunen S et al. alpha-Lipoic acid supplementation enhances heat shock protein production and decreases post exercise lactic acid concentrations in exercised standardbred trotters. Res Vet Sci 2009;87(3):462-7 [Cod. 14865] Gleeson M. Dosing and efficacy of glutamine supplementation in human exercise and sport training. J Nutr. 2008; 138(10):2045S-2049S [Cod. 16690] Miolo A, Mortellaro CM. Artrosi del cane e stress ossidativo-infiammatorio: dalla clinica al meccanismo. Veterinaria 2003, 17(1): 17-33 [Cod. 1865] Khanna D et al. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol. 2007; 7(3):344-51 [Cod. 14199] Matsuno H et al. Effects of an oral administration of glucosamine-chondroitin-quercetin glucoside on the synovial fluid properties in patients with osteoarthritis and rheumatoid arthritis. Biosci Biotechnol Biochem. 2009; 73(2):288-92 [Cod. 14643] Fabris M et al. Quercetin protects canine articular chondrocytes from oxidative damage. Proceedings 1st World Orthopaedic Veterinary Congress- ESVOT - VOS, Munich, 5-8 September, 2002, p.69 [Cod. 3366] Crovace A et al. Surgery plus chondroprotection for canine cranial cruciate ligament (CCL) rupture. A proton-NMR study. Vet Comp Orthop Traumatol, 2006; 19 (4):239-45 [Cod. 12367] 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 41. 42. 43. 44. 45. Invio articoli citati - Gli articoli citati nella sezioni “Riferimenti bibliografici” sono disponibili presso il CeDIS di Innovet (Centro di Documentazione e Informazione Scientifica). Per richiedere l’invio gratuito di una copia (a solo scopo di studio personale) inviare una mail a cedis@innovet.it, indicando il codice riportato tra parentesi alla fine del riferimento bibliografico dell’articolo/i di interesse. Se vuoi essere costantemente aggiornato sulla pubblicazione di nuovi articoli relativi ai temi trattati, registrati sul sito www.innovet.it e potrai accedere a BiblioVet, il servizio di documentazione online disponibile alla sezione CeDIS. Leggendo questo codice QR con il tuo cellulare, visiterai il nostro sito web www.innovet.it Cos’è un codice QR? Vai su www.qurify.com Web: www.innovet.it Email: innovet@innovet.it MB0093 Informazione riservata ai Medici Veterinari. © 2011 – Innovet Italia S.r.l. - Milano - Tutti i diritti di riproduzione, traduzione e adattamento anche parziale sono riservati per tutti i paesi.  http://www.innovet.it http://www.innovet.it http://www.innovet.it http://www.qurify.com

Tabella dei contenuti per la edizione digitale del ARTHRO SYSTEM

Copertina
Il progetto
Gli ingredienti del successo
CondroGEN®
CondroSTRESS®
Appetibilità
Gestione multimodale dei problemi articolari
Riferimenti bibliografici

ARTHRO SYSTEM

ARTHRO SYSTEM - Copertina (Page 1)
ARTHRO SYSTEM - Il progetto (Page 2)
ARTHRO SYSTEM - Gli ingredienti del successo (Page 3)
ARTHRO SYSTEM - CondroGEN® (Page 4)
ARTHRO SYSTEM - CondroSTRESS® (Page 5)
ARTHRO SYSTEM - Appetibilità (Page 6)
ARTHRO SYSTEM - Gestione multimodale dei problemi articolari (Page 7)
ARTHRO SYSTEM - Riferimenti bibliografici (Page 8)
http://www.nxtbook.fr/newpress/Innovet/Arthro_System
http://www.nxtbook.fr/newpress/Innovet/InnVetMed/Ti_sei_lavato_i_denti-2011_03-02
http://www.nxtbook.fr/newpress/Innovet/Linea_Restomyl
http://www.nxtbook.fr/newpress/Innovet/InnVetMed-2-10-Ottobre2009
http://www.nxtbook.fr/newpress/Innovet/InnVetMed-1-8-Febbraio2009
https://www.nxtbookmedia.com